Limited-Stage SCLC Amid a Sea Change Brought on by Immunotherapy: How to Make the Most of the New Evidence for Elevating Curative-Intent Treatment Approaches and Upgrading Long-Standing Standards
- Provider:PVI, PeerView Institute for Medical Education
- Activity Link: https://www.peerview.com/ZPF
- Start Date: 2025-01-27 06:00:00
- End Date: 2025-01-27 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: Source: AstraZeneca (Any division) - Amount: 56608.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest